For PCOS, the mean transcript levels of PWRN2 in the CCMII group was significantly down-regulated by 4.55–fold compared with that in the CCMI/GV group (1.006 ± 0.028 versus 4.602 ± 0.128; Fig. 1A). Here, PWRN2 is linked to polycystic ovary syndrome.